3,4-Epoxy-2,5-dimethyl-hexan | 343268-81-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 环氧化物
• 英文名称: 3,4-Epoxy-2,5-dimethyl-hexan
• 英文别名: 2,3-diisopropyloxirane；2,3-Di(propan-2-yl)oxirane
• CAS: 343268-81-5
• 化学式: C₈H₁₆O
• 分子量: 128.214
• InChiKey: IKASFLJHSHDRIQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3,4-Epoxy-2,5-dimethyl-hexan 、 甲基肼 在 sodium hydroxide 作用下， 生成 2,5-Dimethyl-4-1-methyl-hydrazino>-hexanol-(3)
  参考文献：
  名称：

  一些四氢恶二嗪酮和一些二氢氨基恶二嗪的合成和药理评价。

  摘要：

  DOI：

  10.1021/jm00308a038
• 作为产物：
  描述：

  2,5-二甲-3-己烯 以15%的产率得到
  参考文献：
  名称：

  HINRICHS T. A.; RAMACHANDRAN V.; MURRAY R. W., J. AMER. CHEM. SOC., 1979, 101, NO 5, 1282-1284

  摘要：

  DOI：

文献信息

• Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
  申请人：Mutahi W. Mwangi

  公开号：US20070167435A1

  公开（公告）日：2007-07-19

  Disclosed are compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein: M is CH or N; U and W are each CH, or one of U and W is CH and the other is N; X is a bond, alkylene, —C(O)—, —C(N—OR 5 )—, —C(N—OR 5 )—CH(R 6 )—, —CH(R 6 )—C(N—OR 5 )—, —O—, —OCH 2 —, —CH 2 O— or —S(O) 0-2 —; Y is —O—, —(CH 2 ) 2 —, —C(═O)—, —C(═NOR 7 )— or —SO 0-2 —; Z is a bond, optionally substituted alkylene or alkylene interrupted by a heteroatom or heterocyclic group; R 1 is optionally substituted alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heterocycloalkyl, or benzimidazolyl or a derivative thereof; R 2 is optionally substituted alkyl, alkenyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl or heterocycloalkyl; and the remaining variables are as defined in the specification; compositions and methods for treating an allergy-induced airway response, congestion, diabetes, obesity, an obesity-related disorder, metabolic syndrome and a cognition deficit disorder using said compounds, alone or in combination with other agents.

  揭示了以下化合物的结构式或其药学上可接受的盐或溶剂，其中：M为CH或N；U和W分别为CH，或者U和W中的一个为CH，另一个为N；X为键，烷基，—C(O)—，—C(N—OR5)—，—C(N—OR5)—CH(R6)—，—CH(R6)—C(N—OR5)—，—O—，—OCH2—，—CH2O—或—S(O)0-2—；Y为—O—，—(CH2)2—，—C(═O)—，—C(═NOR7)—或—SO0-2—；Z为键，可选择地取代的烷基或被杂原子或杂环基中断的烷基；R1为可选择地取代的烷基，环烷基，芳基，芳基烷基，杂芳基，杂环烷基或苯并咪唑基或其衍生物；R2为可选择地取代的烷基，烯基，芳基，芳基烷基，杂芳基，杂芳基烷基，环烷基或杂环烷基；其余变量如规范中所定义；使用这些化合物，单独或与其他药剂联合使用，治疗由过敏引起的气道反应、充血、糖尿病、肥胖症、与肥胖有关的疾病、代谢综合征和认知缺陷障碍的组合物和方法。
• PROCESS FOR FUNCTIONALIZATION OF UNSATURATED COMPOUNDS
  申请人：Casciato Stefano

  公开号：US20130211033A1

  公开（公告）日：2013-08-15

  The present invention relates to a process for synthesizing a multifunctional compound, including the reaction of a compound of formula (II) with atmospheric or molecular oxygen, in the presence of at least one aldehyde of formula (III), and optionally in the presence of at least one catalyst or at least one radical initiator; wherein: R 10 , R 20 , R 30 , R 40 , R 50 , L 2 , R 60 , R 7 , R 8 , and R 9 are as described in the claims. The invention also relates to the use of these compounds as monomers for the preparation of polyurethane. The invention also relates to the use of these compounds as monomers of polymers or of biopolymers.

  本发明涉及一种合成多功能化合物的方法，包括将式（II）的化合物与大气或分子氧在至少一种醛（式（III））的存在下反应，可选地在至少一种催化剂或至少一种自由基引发剂的存在下；其中：R10、R20、R30、R40、R50、L2、R60、R7、R8和R9如权利要求中所述。该发明还涉及将这些化合物用作聚氨酯制备中的单体的用途。该发明还涉及将这些化合物用作聚合物或生物聚合物的单体的用途。
• BIOCIDAL BIOPOLYMER COATINGS
  申请人：Georgia Southern Research and Service Foundation, Inc.

  公开号：US20180030284A1

  公开（公告）日：2018-02-01

  Disclosed herein are biopolymer-based biocidal coatings. The coatings have excellent antimicrobial and antifungal properties, and retain their activity over substantially prolonged periods of time.

  本文披露了基于生物聚合物的生物杀菌涂层。这些涂层具有出色的抗菌和抗真菌性能，并且在相当长的时间内保持其活性。
• Substituted aniline derivatives useful as histamine H3 antagonists
  申请人：Solomon M. Daniel

  公开号：US20070142394A1

  公开（公告）日：2007-06-21

  Disclosed are compounds of the formula or a pharmaceutically acceptable salt thereof, wherein M 1 is M 2 is N; X is a bond, optionally substituted alkylene, alkenylene, —O—, —CH 2 N(R 12 )—, —N(R 12 )CH 2 —, —N(R 12 )—, —NHC(O)—, —OCH 2 —, —CH 2 O—, or —S(O) 0-2 —; and Y is —(CH 2 ) 1-2 —, —C(═O)—, —C(═NOR 13 )— or —SO 0-2 —; or M 1 is N; M 2 is N or CH; X is a bond, alkylene, alkenylene, —C(O)—, —NHC(O)—, —OC(O)— or —S(O) 1-2 —; Y is —(CH 2 ) 1-2 —, —C(═O)— or —SO 0-2 —; and when M 2 is CH, Y is also Y is —O— or —C(═NOR 13 )—; Z is a bond or optionally substituted alkylene or alkenylene; U and W are CH, or one is CH and one is N; R 1 is optionally substituted alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heterocycloalkyl; R 2 is optionally substituted alkyl, alkenyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl or heterocycloalkyl; and the remaining variables are as defined in the specification; and compositions and methods of treating obesity, metabolic syndrome and a cognition deficit disorder, alone or in combination with other agents.

  揭示了以下化合物的结构式或其药学上可接受的盐，其中M1为M2为N；X为键合，可选择地取代的烷基，烯基，—O—，—CH2N(R12)—，—N(R12)CH2—，—N(R12)—，—NHC(O)—，—OCH2—，—CH2O—或—S(O)0-2—；Y为—(CH2)1-2—，—C(═O)—，—C(═NOR13)—或—SO0-2—；或者M1为N；M2为N或CH；X为键合，烷基，烯基，—C(O)—，—NHC(O)—，—OC(O)—或—S(O)1-2—；Y为—(CH2)1-2—，—C(═O)—或—SO0-2—；当M2为CH时，Y也为—O—或—C(═NOR13)—；Z为键合或可选择地取代的烷基或烯基；U和W为CH，或其中一个为CH，另一个为N；R1为可选择地取代的烷基，环烷基，芳基，芳基烷基，杂环芳基，杂环烷基；R2为可选择地取代的烷基，烯基，芳基，芳基烷基，杂环芳基，杂环芳基烷基，环烷基或杂环烷基；其余变量如规范中定义；以及治疗肥胖症、代谢综合征和认知缺陷障碍的组合物和方法，可单独使用或与其他药物组合使用。
• Modified ethylene-vinyl alcohol copolymer and method for the production thereof
  申请人：——

  公开号：US20040096683A1

  公开（公告）日：2004-05-20

  Provided is a modified ethylene-vinyl alcohol copolymer (C) having an ethylen content of 5 to 55 mol %, which contains a specific structural unit (I) in an amount of 0.3 to 40 mol % and may be obtained by reacting an ethylene-vinyl alcohol copolymer (A) with a monofunctional epoxy compound (B) having a molecular weight of not more than 500. This can be produced by a method for producing the modified ethylene-vinyl alcohol copolymer (C) which comprises melting and kneading an ethylene-vinyl alcohol copolymer (A) with a monofunctional epoxy compound (B) in an extruder. The modified ethylene-vinyl alcohol copolymer (C) is superior to a unmodified ethylene-vinyl alcohol copolymer (A) in transparency, stretchability, flexibility and flexing resistance due to the specific structural unit (I) incorporated therein, and thus, can be used as a barrier material in various applications requiring the above performance capabilities.

  提供的是一种改性乙烯-醋酸乙烯共聚物(C)，其乙烯含量为5至55摩尔％，其中含有一种特定的结构单元(I)，其含量为0.3至40摩尔％，可通过将乙烯-醋酸乙烯共聚物(A)与分子量不超过500的单官能环氧化合物(B)反应而获得。该改性乙烯-醋酸乙烯共聚物(C)的制备方法包括在挤出机中熔融和揉捏乙烯-醋酸乙烯共聚物(A)与单官能环氧化合物(B)。由于其中包含了特定的结构单元(I)，改性乙烯-醋酸乙烯共聚物(C)在透明度、可伸展性、柔韧性和耐弯曲性方面优于未改性的乙烯-醋酸乙烯共聚物(A)，因此可以用作在需要上述性能能力的各种应用中的障壁材料。